CN107156481A - 一种防治仔猪腹泻的饲料添加剂及其制备方法 - Google Patents
一种防治仔猪腹泻的饲料添加剂及其制备方法 Download PDFInfo
- Publication number
- CN107156481A CN107156481A CN201710363414.4A CN201710363414A CN107156481A CN 107156481 A CN107156481 A CN 107156481A CN 201710363414 A CN201710363414 A CN 201710363414A CN 107156481 A CN107156481 A CN 107156481A
- Authority
- CN
- China
- Prior art keywords
- feed addictive
- grice diarrhoea
- piglet
- diarrhoea
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000002131 composite material Substances 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 22
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229910052901 montmorillonite Inorganic materials 0.000 claims abstract description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 13
- 239000008103 glucose Substances 0.000 claims abstract description 13
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 12
- 239000000654 additive Substances 0.000 claims abstract description 9
- 230000000996 additive effect Effects 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 4
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims abstract description 3
- 240000006079 Schisandra chinensis Species 0.000 claims description 11
- 235000013399 edible fruits Nutrition 0.000 claims description 11
- 244000163122 Curcuma domestica Species 0.000 claims description 10
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 10
- 235000003373 curcuma longa Nutrition 0.000 claims description 10
- 235000013976 turmeric Nutrition 0.000 claims description 10
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 9
- 239000001702 nutmeg Substances 0.000 claims description 9
- 235000005911 diet Nutrition 0.000 claims description 7
- 230000037213 diet Effects 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- 229930003448 Vitamin K Natural products 0.000 claims description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 5
- 235000019168 vitamin K Nutrition 0.000 claims description 5
- 239000011712 vitamin K Substances 0.000 claims description 5
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 5
- 229940046010 vitamin k Drugs 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003451 Vitamin B1 Natural products 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 241000411851 herbal medicine Species 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 238000001802 infusion Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 244000270834 Myristica fragrans Species 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 12
- 210000000936 intestine Anatomy 0.000 abstract description 5
- 238000009360 aquaculture Methods 0.000 abstract description 4
- 244000144974 aquaculture Species 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 241000282887 Suidae Species 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 description 13
- 241000498779 Myristica Species 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 241000726221 Gemma Species 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 239000004575 stone Substances 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 210000003097 mucus Anatomy 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000008855 peristalsis Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 235000015489 Emblica officinalis Nutrition 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 241000702670 Rotavirus Species 0.000 description 2
- 235000011517 Terminalia chebula Nutrition 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000589875 Campylobacter jejuni Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000224483 Coccidia Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 244000119298 Emblica officinalis Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 244000277583 Terminalia catappa Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000003450 growing effect Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930192961 schisandrol Natural products 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- -1 supply energy Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Environmental Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及饲料技术领域,特别涉及一种防治仔猪腹泻的饲料添加剂及其制备方法;由以下按重量份计的原料组成:解淀粉芽孢杆菌液10~20、枯草芽孢杆菌液10~20、蒙脱石20~30、葡萄糖10~20、复合维生素5~10、复合中草药10~20;本发明的添加剂,对仔猪的腹泻情况具有显著的防治效果,能有效的降低仔猪的腹泻发病率至0.7%,对已经发生腹泻情况的仔猪的治愈率达98.4%以上,通过合理的配比,能有效改善仔猪肠道菌群失调,降低仔猪腹泻的发生,减少经济损失、为猪养殖业持续健康发展发挥了极其重要的意义。
Description
技术领域
本发明涉及饲料技术领域,特别涉及一种防治仔猪腹泻的饲料添加剂及其制备方法。
背景技术
随着规模化养殖水平不断提高,仔猪早期断奶越来越普遍,它不仅能提高母猪的生产力和圈舍设备的利用率,而且可以减少疾病的母源传播,还可以提高仔猪的生长性能以及后期的生长效果,然而,仔猪断乳后消化道发育尚未完善,胃酸分泌不足、消化酶分泌较少,仔猪断奶后常常出现消化不良、抗病力下降及腹泻等现象,最终表现为生长抑制,而以仔猪腹泻发病率最高,严重者直接导致仔猪的死亡,仔猪腹泻是由多种因素相互作用所导致的一种临床症状,常见的病原有细菌、病毒、寄生虫等,导致仔猪腹泻的原因有多种,包括卫生条件差,饲养员对温度变化不敏感,湿度大,使仔猪长期处于应激状态而发病,哺乳母乳奶水差,不能满足仔猪需求,诱发仔猪水样腹泻,细菌(大肠杆菌、魏氏梭菌)、病毒(流行性腹泻、传染性胃肠炎、轮状病毒)及寄生虫(球虫)等都会导致仔猪腹泻,且由于仔猪各器官都没有发育成熟,也导致腹泻最难治疗。
仔猪是整个猪养殖业的前提保障,因此,本研究者通过仔猪的生理特点,针对仔猪发育需求,研发一种能有效提高仔猪免疫力,减少仔猪的腹泻发病率,提高仔猪的存活率的添加剂,对猪养殖业来说具有重要意义,同时也为禽畜养殖业中腹泻疾病治疗提供一种新思路。
发明内容
本发明为解决上述技术问题,提供了一种防治仔猪腹泻的饲料添加剂及其制备方法。
具体是通过以下技术方案来实现的:
一种防治仔猪腹泻的饲料添加剂,由以下按重量份计的原料组成:解淀粉芽孢杆菌液10~20、枯草芽孢杆菌液10~20、蒙脱石20~30、葡萄糖10~20、复合维生素5~10、复合中草药10~20。
由以下按重量份计的原料组成:解淀粉芽孢杆菌液15、枯草芽孢杆菌液15、蒙脱石25、葡萄糖15、复合维生素8、复合中草药15。
所述的蒙脱石,其含量≥95%。
所述的复合维生素,是维生素A、维生素D、维生素E、维生素B1、维生素K中的两种或两种以上的混合物。
所述的复合中草药,是将五味子、肉豆蔻、柯子、姜黄按1∶0.2~0.5∶1.2~1.8:0.8~1.2的质量比混合。
所述的防治仔猪腹泻饲料添加剂的制备方法,其特征在于,先将复合中草药、蒙脱石混合,研磨成粉,再与剩下的原料混合,拌匀,经真空干燥后,即可。
所述的防治仔猪腹泻饲料添加剂的制备方法,其特征在于,先将复合中草药粉碎,加水熬煮成含水量为15~20%的浸膏,与剩余的其它原料混合,拌匀即可。
所述的防治仔猪腹泻的饲料添加剂,将添加剂与仔猪日粮按0.5~1.5%:1的质量比混合,对仔猪进行喂食,当仔猪腹泻时,将添加剂与仔猪日粮按1~3%:1的质量比混合,对仔猪进行喂食。
以下对本发明采用的原料的功效作进一步的说明:
蒙脱石:蒙脱石在饲料上应用具有脱霉、止泻等作用,并且安全绿色,蒙脱石药理研究表明,它对大肠杆菌、霍乱弧菌、空肠弯曲菌、金黄色葡萄球菌和轮状病毒以及胆盐都有较好的吸附作用;对细菌毒素有固定作用;蒙脱石可以吸附各种消化道致病因子,蒙脱石与消化道粘液蛋白静电结合,可以增加粘液量并改善粘液质量提高粘液的内聚力和弹性,从而对消化道粘膜起保护和修复作用,蒙脱石对各种病因引起的腹泻均有效。
葡萄糖:能补充体内水分和糖分,具有补充体液、供给能量、补充血糖、强心利尿、解毒等作用,用于出汗、呕吐、腹泻引起的体液丢失。
维生素A:维生素A可以调节上皮组织细胞的生长,维持上皮组织的正常形态与功能,有助于维持免疫系统功能正常,能加强对传染病特别是呼吸道感染及寄生虫感染的身体抵抗力。
维生素D:缺乏维生素D时,会出现骨头和关节疼痛,肌肉萎缩,失眠,紧张以及痢疾腹泻等情况。
维生素E:唇炎、恶心、呕吐、眩晕、视力模糊、胃肠功能及性腺功能紊乱、免疫力下降、代谢失常等症状
维生素B1:能增进食欲,维持神经正常活动,缺乏维生素B1时,造成胃肠蠕动缓慢,消化道分泌减少,食欲不振、消化不良等障碍。
维生素K:维生素K可增加肠道蠕动和分泌功能,缺乏维生素K时平滑肌张力及收缩减弱,它还可影响一些激素的代谢
五味子:五味子性温,味甘、酸,归肺、心、肾经,适用于气津两伤,阴血不足,久泻不止等症,五味子能促进肝糖原的合成,使糖代谢加强,又能增加肝细胞蛋白质的合成。对淋巴细胞DNA合成有促进作用,使淋巴母细胞生成增多,并促进脾免疫功能,而五味子醇能增强肾上腺皮质激素的免疫抑制作用,能对抗同种异体组织移植排斥反应。
肉豆蔻:温中行气,涩肠止泻。用于脾胃虚寒,久泻不止,脘腹胀痛,食少呕吐,对胃肠道刺激作用,所含挥发油对胃肠道有刺激作用,且具有祛风作用,能促进胃液的分泌和刺激胃肠蠕动。
柯子:诃子为清凉解毒中药,诃子主治久泻;久痢;脱肛;有温中祛寒、涩肠止泻、理气之功效用于治疗脾胃虚寒、泻痢日久不愈之脘腹冷痛、便下脓血白多赤少、甚或脱肛者。
姜黄:姜黄中的主要成分-姜黄素,具有抗氧化、抗肿瘤、降血脂、降血糖、抗溃疡、保护肝脏、抗心肌缺血、抗抑郁、抗菌、消炎、抗病毒和抗真菌等作用,对细菌、病毒引起的腹泻具有显著的疗效。
综上所述,本发明的有益效果在于:本发明的添加剂,对仔猪的腹泻情况具有显著的防治效果,能有效的降低仔猪的腹泻发病率至0.7%,对已经发生腹泻情况的仔猪的治愈率达98.4%以上,通过合理的配比,能有效改善仔猪肠道菌群失调,降低仔猪腹泻的发生,减少经济损失、为猪养殖业持续健康发展发挥了极其重要的意义。
通过有益细菌的添加,能迅速消耗肠道中的游离氧,造成肠道低氧,促进有益厌氧菌生长,并产生乳酸等有机酸类,降低肠道PH值,间接抑制其它致病菌生长,枯草芽孢杆菌菌体自身合成α-淀粉酶、蛋白酶、脂肪酶、纤维素酶等酶类,在消化道中与仔猪体内的消化酶类一同发挥作用,耐酸碱,在酸性胃环境中能保持活性,可以耐唾液和胆汁的攻击,是微生物中可100%直达大小肠的活菌。
具体实施方式
下面对本发明的具体实施方式作进一步详细的说明,但本发明并不局限于这些实施方式,任何在本实施例基本精神上的改进或代替,仍属于本发明权利要求所要求保护的范围。
实施例1
一种防治仔猪腹泻的饲料添加剂,由以下按重量份计的原料组成:解淀粉芽孢杆菌液10kg、枯草芽孢杆菌液10kg、蒙脱石20kg、葡萄糖10kg、复合维生素5kg、复合中草药10kg。
所述的复合中草药,是将五味子、肉豆蔻、柯子、姜黄按1∶0.2∶1.2∶0.8的质量比混合。
所述的防治仔猪腹泻饲料添加剂的制备方法,其特征在于,先将复合中草药、蒙脱石混合,研磨成粉,再与剩下的原料混合,拌匀,经真空干燥后,即可。
实施例2
一种防治仔猪腹泻的饲料添加剂,由以下按重量份计的原料组成:解淀粉芽孢杆菌液20kg、枯草芽孢杆菌液20kg、蒙脱石30kg、葡萄糖20kg、复合维生素10kg、复合中草药20kg。
所述的复合中草药,是将五味子、肉豆蔻、柯子、姜黄按1∶0.5∶1.8∶1.2的质量比混合。
所述的防治仔猪腹泻饲料添加剂的制备方法,其特征在于,先将复合中草药、蒙脱石混合,研磨成粉,再与剩下的原料混合,拌匀,经真空干燥后,即可。
实施例3
一种防治仔猪腹泻的饲料添加剂,由以下按重量份计的原料组成:解淀粉芽孢杆菌液15kg、枯草芽孢杆菌液15kg、蒙脱石25kg、葡萄糖15kg、复合维生素8kg、复合中草药15kg。
所述的复合中草药,是将五味子、肉豆蔻、柯子、姜黄按1∶0.4∶1.5∶1的质量比混合。
所述的防治仔猪腹泻饲料添加剂的制备方法,其特征在于,先将复合中草药、蒙脱石混合,研磨成粉,再与剩下的原料混合,拌匀,经真空干燥后,即可。
实施例4
一种防治仔猪腹泻的饲料添加剂,由以下按重量份计的原料组成:解淀粉芽孢杆菌液10kg、枯草芽孢杆菌液20kg、蒙脱石20kg、葡萄糖20kg、复合维生素5kg、复合中草药20kg。
所述的复合中草药,是将五味子、肉豆蔻、柯子、姜黄按1∶0.2∶1.8∶0.8的质量比混合。
所述的防治仔猪腹泻饲料添加剂的制备方法,其特征在于,先将复合中草药、蒙脱石混合,研磨成粉,再与剩下的原料混合,拌匀,经真空干燥后,即可。
实施例5
一种防治仔猪腹泻的饲料添加剂,由以下按重量份计的原料组成:解淀粉芽孢杆菌液20kg、枯草芽孢杆菌液10kg、蒙脱石30kg、葡萄糖10kg、复合维生素5kg、复合中草药15kg。
所述的复合中草药,是将五味子、肉豆蔻、柯子、姜黄按1∶0.5∶1.2∶1.2的质量比混合。
所述的防治仔猪腹泻饲料添加剂的制备方法,其特征在于,先将复合中草药、蒙脱石混合,研磨成粉,再与剩下的原料混合,拌匀,经真空干燥后,即可。
实施例6
一种防治仔猪腹泻的饲料添加剂,由以下按重量份计的原料组成:解淀粉芽孢杆菌液15kg、枯草芽孢杆菌液20kg、蒙脱石25kg、葡萄糖10kg、复合维生素8kg、复合中草药10kg。
所述的复合中草药,是将五味子、肉豆蔻、柯子、姜黄按1∶0.2∶1.8:0.8的质量比混合。
所述的防治仔猪腹泻饲料添加剂的制备方法,其特征在于,先将复合中草药粉碎,加水熬煮成含水量为15~20%的浸膏,与剩余的其它原料混合,拌匀即可。
实验例
1、随机选取若干头年龄、健康状况、进食情况相同的仔猪,随机分为3组,采用日常管理方式进行喂养,且均由同一人进行喂养,不同之处在于,第一组将添加剂与仔猪日粮按0.5~1.5%∶1的质量比混合,对仔猪进行喂食,第二组在仔猪日粮中添加市售的预防腹泻的药物,第三组不添加任何药物,试验时间为20d,分别对仔猪的腹泻发病率、以及抗生素的使用情况进行统计,结果如表1所示:
表1
项目 | 发病率% | 抗生素使用次数 |
第一组 | 0.7 | 0 |
第二组 | 1.2 | 1 |
第三组 | 3 | 5 |
2、随机选取若干头年龄、患病情况相同的仔猪,随机分为2组,采用日常管理方式进行喂养,且均由同一人进行喂养,不同之处在于,第一组将添加剂与仔猪日粮按1~3%∶1的质量比混合,对仔猪进行喂食,第二组在将市售治疗腹泻的药物与日粮按第一组的混合比混合,对仔猪进行喂食,试验时间为20d,以有效、无效、缓解来表示对仔猪的治疗情况,其中,有效代表治愈,已经恢复到发病前的状态,无效代表没有效果,病情加重或者死亡,好转率代表病情有所缓解,有待进一步治疗,结果如表2所示:
表2
项目 | 有效率% | 无效率% | 好转率% |
第一组 | 98.4 | 0 | 1.6 |
第二组 | 93.5 | 4 | 2.5 |
Claims (8)
1.一种防治仔猪腹泻的饲料添加剂,其特征在于,由以下按重量份计的原料组成:解淀粉芽孢杆菌液10~20、枯草芽孢杆菌液10~20、蒙脱石20~30、葡萄糖10~20、复合维生素5~10、复合中草药10~20。
2.如权利要求1所述的防治仔猪腹泻的饲料添加剂,其特征在于,由以下按重量份计的原料组成:解淀粉芽孢杆菌液15、枯草芽孢杆菌液15、蒙脱石25、葡萄糖15、复合维生素8、复合中草药15。
3.如权利要求1所述的防治仔猪腹泻的饲料添加剂,其特征在于,所述的蒙脱石,其含量≥95%。
4.如权利要求1所述的防治仔猪腹泻的饲料添加剂,其特征在于,所述的复合维生素,是维生素A、维生素D、维生素E、维生素B1、维生素K中的两种或两种以上的混合物。
5.如权利要求1所述的防治仔猪腹泻的饲料添加剂,其特征在于,所述的复合中草药,是将五味子、肉豆蔻、柯子、姜黄按1∶0.2~0.5∶1.2~1.8∶0.8~1.2的质量比混合。
6.如权利要求1所述的防治仔猪腹泻饲料添加剂的制备方法,其特征在于,先将复合中草药、蒙脱石混合,研磨成粉,再与剩下的原料混合,拌匀,经真空干燥后,即可。
7.如权利要求1所述的防治仔猪腹泻饲料添加剂的制备方法,其特征在于,先将复合中草药粉碎,加水熬煮成含水量为15~20%的浸膏,与剩余的其它原料混合,拌匀即可。
8.如权利要求1所述的防治仔猪腹泻的饲料添加剂,其特征在于,将添加剂与仔猪日粮按0.5~1.5%∶1的质量比混合,对仔猪进行喂食,当仔猪腹泻时,将添加剂与仔猪日粮按1~3%∶1的质量比混合,对仔猪进行喂食。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710363414.4A CN107156481A (zh) | 2017-05-22 | 2017-05-22 | 一种防治仔猪腹泻的饲料添加剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710363414.4A CN107156481A (zh) | 2017-05-22 | 2017-05-22 | 一种防治仔猪腹泻的饲料添加剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107156481A true CN107156481A (zh) | 2017-09-15 |
Family
ID=59815899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710363414.4A Pending CN107156481A (zh) | 2017-05-22 | 2017-05-22 | 一种防治仔猪腹泻的饲料添加剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107156481A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107811114A (zh) * | 2017-10-30 | 2018-03-20 | 双胞胎(集团)股份有限公司 | 一种具有防止仔猪营养性腹泻的饲料添加剂 |
CN113288919A (zh) * | 2021-06-17 | 2021-08-24 | 浙江大学 | 解淀粉芽孢杆菌在预防断奶仔猪腹泻中的应用 |
CN113907208A (zh) * | 2021-11-04 | 2022-01-11 | 淮阴工学院 | 一种预防仔猪腹泻的饲料添加剂及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102429096A (zh) * | 2011-11-10 | 2012-05-02 | 青岛根源生物技术集团有限公司 | 一种饲料添加剂及其在减轻仔猪腹泻中的应用 |
CN104171377A (zh) * | 2014-07-10 | 2014-12-03 | 南宁荣港生物科技有限公司 | 防治仔猪腹泻的中药合生元饲料添加剂及其制备方法 |
CN106509439A (zh) * | 2016-11-16 | 2017-03-22 | 山西大禹生物工程股份有限公司 | 替代抗生素预防断奶仔猪腹泻的饲料添加剂 |
-
2017
- 2017-05-22 CN CN201710363414.4A patent/CN107156481A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102429096A (zh) * | 2011-11-10 | 2012-05-02 | 青岛根源生物技术集团有限公司 | 一种饲料添加剂及其在减轻仔猪腹泻中的应用 |
CN104171377A (zh) * | 2014-07-10 | 2014-12-03 | 南宁荣港生物科技有限公司 | 防治仔猪腹泻的中药合生元饲料添加剂及其制备方法 |
CN106509439A (zh) * | 2016-11-16 | 2017-03-22 | 山西大禹生物工程股份有限公司 | 替代抗生素预防断奶仔猪腹泻的饲料添加剂 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107811114A (zh) * | 2017-10-30 | 2018-03-20 | 双胞胎(集团)股份有限公司 | 一种具有防止仔猪营养性腹泻的饲料添加剂 |
CN113288919A (zh) * | 2021-06-17 | 2021-08-24 | 浙江大学 | 解淀粉芽孢杆菌在预防断奶仔猪腹泻中的应用 |
CN113907208A (zh) * | 2021-11-04 | 2022-01-11 | 淮阴工学院 | 一种预防仔猪腹泻的饲料添加剂及其制备方法和应用 |
CN113907208B (zh) * | 2021-11-04 | 2024-02-23 | 淮阴工学院 | 一种预防仔猪腹泻的饲料添加剂及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102940151B (zh) | 用于提高蛋鸭产蛋性能的饲料 | |
CN109464487A (zh) | 抗幽门螺杆菌的益生菌复合物及其制备方法 | |
CN109770078B (zh) | 一种预防哺乳期犊牛腹泻的饲料添加剂及其使用方法 | |
CN104206539A (zh) | 一种益生菌婴幼儿奶粉 | |
CN103125779A (zh) | 一种肉鸡用生物中药饲料添加剂及其制备方法 | |
CN102488117A (zh) | 一种防治仔猪腹泻的复合制剂及其制备方法和应用 | |
CN107114584B (zh) | 一种哺乳母猪用的饲料添加剂及其制作使用方法 | |
CN101926415A (zh) | 一种可完全代替母猪奶的仔猪奶粉 | |
CN103156061A (zh) | 复合微生物活性添加剂 | |
CN107156481A (zh) | 一种防治仔猪腹泻的饲料添加剂及其制备方法 | |
CN105994941A (zh) | 一种微生物发酵制备的无抗饲料 | |
CN105767543A (zh) | 一种仔猪用健胃促消化中药微生态制剂及其制备方法 | |
CN104255919A (zh) | 一种乳猪奶粉 | |
CN108261515A (zh) | 一种用于防治僵猪的中药组合物、中药微生态制剂及其制备方法和应用 | |
CN106889329A (zh) | 一种用于育肥促生长复合生物制剂及其制备方法 | |
CN104286558A (zh) | 一种中药复合乳猪料 | |
CN111820285A (zh) | 适用于胃肠胀气婴幼儿食用的奶粉及其制备方法 | |
CN107348136A (zh) | 一种植物性促断奶仔猪胃肠消化机能的饲料添加剂及应用 | |
CN110692847A (zh) | 一种兔用无抗生素混合型饲料添加剂 | |
CN106615817A (zh) | 猪仔饲料添加剂及其制备方法 | |
CN103689276B (zh) | 一种有效防治仔猪腹泻的中草药饲料添加剂 | |
CN101698011B (zh) | 治疗畜禽流行性腹泻的药物 | |
CN104322985A (zh) | 一种乳猪饲料 | |
CN107961260A (zh) | 治疗、预防禽类大肠杆菌性腹泻病的药剂及其制备方法 | |
CN107279234A (zh) | 有益肠道健康的饼干 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170915 |
|
RJ01 | Rejection of invention patent application after publication |